MOHAN PANKAJ (Chairman, President and CEO) purchased 136.7% of their position (34.38K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 10/27/2023ACC: 0001493152-23-038573
DirectorOfficer· Chairman, President and CEO
Since Apr 2020
+103.13K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
103.13K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.38K
Price / share
—
Trade value
—
% of position
136.7%
10/27/2023
25.15K→59.53K
Total
Net shares
+34.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/27/2023 | P · Purchase | +34.38K | — | — | 136.7% | 25.15K | 59.53K |
| Total | +34.38K | $0.00 | ||||||
Derivative Transactions1
Warrant to Purchase Common Stock
Direct
Converts to
Common Stock
68.75K shares
Shares
+68.75K
Strike price
1.60
Held after
68.75K
Exercisable
—
10/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common Stock Direct | Common Stock68.75K shares | 10/27/2023 | P · Purchase | +68.75K | 1.60 | — | 68.75K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned25.00
Common Stock
IndirectShares owned3.02K
Total
3.05K indirect3.05K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.00 | Indirect |
| Common Stock | 3.02K | Indirect |
| Total | 3.05K | 3.05K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported